schizophrenia
Conditions
Interventions
aripiprazole once monthly, paliperidone palmitate or risperidone long-acting injection
Sponsors
Department of Neuropsychiatry, Kansai Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of schizophrenia and schizoaffective disorder according to DSM-IV criteria PANSS score 100 or less and the item of delusions and hallucinations in positive symptom 4 or less Treatment with oral aripiprazole, risperidone, paliperidone 2 months or more, or patient who could be confirmed efficacy and tolerability of these antipsychotics now or past. switching from oral antipsychotic to long-acting injection JART score 70 or more Being >= 20 years old and competent to contact
Exclusion criteria
Exclusion criteria: Subjects are difficulty in accomplishment of the interview Subjects using antipsychotics 3 or more Subjects who principal investigator decide unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) Interview to patients for using Grounded Theory Approach | — |
Secondary
| Measure | Time frame |
|---|---|
| Specific level of functioning scale (SLOF) Positive and negative syndrome (PANSS) Drug-Induced extrapyramidal symptoms scale (DIEPSS) Japanese adult reading test (JART) Beck Cognitive Insight Scale(BCIS) | — |
Countries
Japan
Contacts
Public ContactYosuke Koshikawa
Kansai Medical University Department of Neuropsychiatry
Outcome results
None listed